Yıl: 2021 Cilt: 20 Sayı: 4 Sayfa Aralığı: 247 - 251 Metin Dili: İngilizce DOI: 10.4274/uob.galenos.2021.2021.2.1 İndeks Tarihi: 26-05-2022

Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey

Öz:
Objective: Nephron-sparing surgery (NSS) is the first-line treatment for T1N0M0 renal tumors (RT). The aim of this multicentric retrospective study is to investigate the national trends and the effect of non-tumoral factors in the preference of NSS as treatment of T1 RT in Turkey. Materials and Methods: Relevant data for patients operated between 1997 and 2017 was collected from the Urologic Cancer Database-Kidney Urooncology Association, Turkey (UroCaD-K). Results: We included 3195 T1N0M0 RT patients in this study. There was a significant increase in the number of NSS performed with time, 9.26% between 1997- 2002 to 54.78% between 2013-2017 (p<0.001). NSS proportion decreased with increasing age (p<0.001); but increased with better hospital facility (p<0.001). From multivariate analysis; younger age, later operation date, larger hospital size with higher nephrectomy centers like university hospitals were independently associated non-tumoral factors favoring NSS over radical nephrectomy (RN). Conclusion: We observed significant disparity in the use of NSS for T1 RT among the elderly (>61 years), small hospital size (≤500 beds), lower nephrectomy volume (<100 nephrectomies/year), and Non-University Hospitals. This disparity can be resolved by persistent education of the residents and urologists with periodic courses and practical training, increasing the funds and strengthening the technical equipment of centers, thereby favoring the performance of NSS even in smaller centers. This will ensure that suitable patients are treated with NSS rather than RN, regardless of the hospital type.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ljungberg B, Albiges L, Bensalah K, et al. EAU guidelines on renal cell carcinoma. 2020;1:1-73.
  • 2. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-552.
  • 3. Arnold ML, Thiel DD, Diehl N, et al. Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy. BMC Urol 2013;13:52.
  • 4. Pierorazio PM, Johnson MH, Patel HD, et al. Management of renal masses and localized renal cancer: systematic review and metaanalysis. J Urol 2016;196:989-999.
  • 5. Huang WC, Elkin EB, Levey AS, et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181:55-61; discussion 61-52.
  • 6. Kates M, Badalato GM, Pitman M, et al. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186:1247-1253.
  • 7. Weight CJ, Larson BT, Fergany AF, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 2010;183:1317-1323.
  • 8. Scosyrev E, Messing EM, Sylvester R, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65:372-377.
  • 9. Poulakis V, Witzsch U, de Vries R, et al. Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery. Urology 2003;62:814-820.
  • 10. Huang WC, Donin NM, Levey AS, et al. Chronic kidney disease and kidney cancer surgery: new perspectives. J Urol 2020;203:475-485.
  • 11. Dulabon LM, Lowrance WT, Russo P, et al. Trends in renal tumor surgery delivery within the United States. Cancer 2010;116:2316-2321.
  • 12. Patel SG, Penson DF, Pabla B, et al. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 2012;187:816-821.
  • 13. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381.
  • 14. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208.
  • 15. Hollenbeck BK, Taub DA, Miller DC, et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006;67:254-259.
  • 16. Zini L, Patard JJ, Capitanio U, et al. The use of partial nephrectomy in European tertiary care centers. Eur J Surg Oncol 2009;35:636-642.
  • 17. Kim SP, Gross CP, Meropol N, et al. National treatment trends among older patients with T1-localized renal cell carcinoma. Urol Oncol 2017;35:113.e15-113.e21. doi: 10.1016/j.urolonc.2016.10.008.
  • 18. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-2127.
APA KUZGUNBAY B, Yaycioglu O, ÖZKAN T, AKDOĞAN B, Sozen T, BAYAZIT Y, Izol V, Ozden E, Bozkurt O, Baltacı S, TINAY İ, Ataus S (2021). Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. , 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
Chicago KUZGUNBAY BARIŞ,Yaycioglu Ozgur,ÖZKAN Tayyar Alp,AKDOĞAN Bülent,Sozen Tevfik Sinan,BAYAZIT YILDIRIM,Izol Volkan,Ozden Ender,Bozkurt Ozan,Baltacı Sümer,TINAY İlker,Ataus Suleyman Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. (2021): 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
MLA KUZGUNBAY BARIŞ,Yaycioglu Ozgur,ÖZKAN Tayyar Alp,AKDOĞAN Bülent,Sozen Tevfik Sinan,BAYAZIT YILDIRIM,Izol Volkan,Ozden Ender,Bozkurt Ozan,Baltacı Sümer,TINAY İlker,Ataus Suleyman Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. , 2021, ss.247 - 251. 10.4274/uob.galenos.2021.2021.2.1
AMA KUZGUNBAY B,Yaycioglu O,ÖZKAN T,AKDOĞAN B,Sozen T,BAYAZIT Y,Izol V,Ozden E,Bozkurt O,Baltacı S,TINAY İ,Ataus S Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. . 2021; 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
Vancouver KUZGUNBAY B,Yaycioglu O,ÖZKAN T,AKDOĞAN B,Sozen T,BAYAZIT Y,Izol V,Ozden E,Bozkurt O,Baltacı S,TINAY İ,Ataus S Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. . 2021; 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
IEEE KUZGUNBAY B,Yaycioglu O,ÖZKAN T,AKDOĞAN B,Sozen T,BAYAZIT Y,Izol V,Ozden E,Bozkurt O,Baltacı S,TINAY İ,Ataus S "Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey." , ss.247 - 251, 2021. 10.4274/uob.galenos.2021.2021.2.1
ISNAD KUZGUNBAY, BARIŞ vd. "Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey". (2021), 247-251. https://doi.org/10.4274/uob.galenos.2021.2021.2.1
APA KUZGUNBAY B, Yaycioglu O, ÖZKAN T, AKDOĞAN B, Sozen T, BAYAZIT Y, Izol V, Ozden E, Bozkurt O, Baltacı S, TINAY İ, Ataus S (2021). Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. Üroonkoloji Bülteni, 20(4), 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
Chicago KUZGUNBAY BARIŞ,Yaycioglu Ozgur,ÖZKAN Tayyar Alp,AKDOĞAN Bülent,Sozen Tevfik Sinan,BAYAZIT YILDIRIM,Izol Volkan,Ozden Ender,Bozkurt Ozan,Baltacı Sümer,TINAY İlker,Ataus Suleyman Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. Üroonkoloji Bülteni 20, no.4 (2021): 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
MLA KUZGUNBAY BARIŞ,Yaycioglu Ozgur,ÖZKAN Tayyar Alp,AKDOĞAN Bülent,Sozen Tevfik Sinan,BAYAZIT YILDIRIM,Izol Volkan,Ozden Ender,Bozkurt Ozan,Baltacı Sümer,TINAY İlker,Ataus Suleyman Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. Üroonkoloji Bülteni, vol.20, no.4, 2021, ss.247 - 251. 10.4274/uob.galenos.2021.2021.2.1
AMA KUZGUNBAY B,Yaycioglu O,ÖZKAN T,AKDOĞAN B,Sozen T,BAYAZIT Y,Izol V,Ozden E,Bozkurt O,Baltacı S,TINAY İ,Ataus S Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. Üroonkoloji Bülteni. 2021; 20(4): 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
Vancouver KUZGUNBAY B,Yaycioglu O,ÖZKAN T,AKDOĞAN B,Sozen T,BAYAZIT Y,Izol V,Ozden E,Bozkurt O,Baltacı S,TINAY İ,Ataus S Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey. Üroonkoloji Bülteni. 2021; 20(4): 247 - 251. 10.4274/uob.galenos.2021.2021.2.1
IEEE KUZGUNBAY B,Yaycioglu O,ÖZKAN T,AKDOĞAN B,Sozen T,BAYAZIT Y,Izol V,Ozden E,Bozkurt O,Baltacı S,TINAY İ,Ataus S "Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey." Üroonkoloji Bülteni, 20, ss.247 - 251, 2021. 10.4274/uob.galenos.2021.2021.2.1
ISNAD KUZGUNBAY, BARIŞ vd. "Non-Tumoral Factors Affecting The Preference of Nephron-Sparing Surgery in The Treatment of Stage 1 Renal Cell Carcinoma Patients in Turkey". Üroonkoloji Bülteni 20/4 (2021), 247-251. https://doi.org/10.4274/uob.galenos.2021.2021.2.1